Importance of specific amino acids in protein binding sites for heparin and heparan sulfate.

[1]  Á. Furka,et al.  General method for rapid synthesis of multicomponent peptide mixtures. , 2009, International journal of peptide and protein research.

[2]  R A Houghten,et al.  Simplified procedure for carrying out simultaneous multiple hydrogen fluoride cleavages of protected peptide resins. , 2009, International journal of peptide and protein research.

[3]  J. Weiler,et al.  Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. , 1995, Archives of biochemistry and biophysics.

[4]  R. Linhardt,et al.  Directional immobilization of heparin onto beaded supports. , 1994, Analytical biochemistry.

[5]  M. Pantoliano,et al.  Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. , 1994, Biochemistry.

[6]  R. St Charles,et al.  The three-dimensional structure of bovine platelet factor 4 at 3.0-A resolution. , 1989, The Journal of biological chemistry.

[7]  T. Nakamura,et al.  Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. , 1994, The Journal of biological chemistry.

[8]  K. Brunden,et al.  pH‐Dependent Binding of Synthetic β‐Amyloid Peptides to Glycosaminoglycans , 1993 .

[9]  D C Rees,et al.  Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor. , 1993, Structure.

[10]  H. Margalit,et al.  Comparative analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues. , 1993, The Journal of biological chemistry.

[11]  H. Itoh,et al.  Domain structure of the 90-kDa stress protein: heparin- and antibody-binding domain. , 1993, The International journal of biochemistry.

[12]  R. Carrell,et al.  Heparin binding site, conformational change, and activation of antithrombin. , 1992, Biochemistry.

[13]  R. Akeson,et al.  The neural cell adhesion molecule (NCAM) heparin binding domain binds to cell surface heparan sulfate proteoglycans , 1992, Journal of neuroscience research.

[14]  J. Cassiman,et al.  Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. , 1992, The Journal of biological chemistry.

[15]  S. Marklund,et al.  The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity. , 1992, The Journal of biological chemistry.

[16]  T. McCaffrey,et al.  Transforming growth factor‐β1 is a heparin‐binding protein: Identification of putative heparin‐binding regions and isolation of heparins with varying affinity for TGF‐β1 , 1992 .

[17]  K. Lam,et al.  A new type of synthetic peptide library for identifying ligand-binding activity , 1992, Nature.

[18]  K. Preissner,et al.  Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation. , 1992, The Journal of biological chemistry.

[19]  F. Church,et al.  Heparin binding to protein C inhibitor. , 1992, The Journal of biological chemistry.

[20]  M. Sobel,et al.  Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. , 1992, The Journal of biological chemistry.

[21]  K. Preissner,et al.  Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin. , 1992, The Journal of biological chemistry.

[22]  J. Lawler,et al.  Cloning and sequencing of chicken thrombospondin. , 1991, The Journal of biological chemistry.

[23]  I. Pettersson,et al.  Biosynthesis of heparin. Purification of a 110-kDa mouse mastocytoma protein required for both glucosaminyl N-deacetylation and N-sulfation. , 1991, The Journal of biological chemistry.

[24]  J. Schwarzbauer,et al.  Localization of the major heparin-binding site in fibronectin. , 1991, The Journal of biological chemistry.

[25]  R L Jackson,et al.  Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. , 1991, Physiological reviews.

[26]  A. Skubitz,et al.  Recognition of the A chain carboxy-terminal heparin binding region of fibronectin involves multiple sites: two contiguous sequences act independently to promote neural cell adhesion , 1990, The Journal of cell biology.

[27]  J. Smith,et al.  Heparin binding domain of antithrombin III: characterization using a synthetic peptide directed polyclonal antibody. , 1990, Biochemistry.

[28]  X. J. Sun,et al.  Evidence that arginine-129 and arginine-145 are located within the heparin binding site of human antithrombin III. , 1990, Biochemistry.

[29]  C. Romanin,et al.  Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action. , 1990, The Journal of biological chemistry.

[30]  K. Mayo,et al.  Human Platelet Factor 4 and Its C-Terminal Peptides: Heparin Binding and Clearance from the Circulation , 1990, Thrombosis and Haemostasis.

[31]  A. Skubitz,et al.  RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities , 1990, The Journal of cell biology.

[32]  E. Tsilibary,et al.  Mapping of three major heparin-binding sites on laminin and identification of a novel heparin-binding site on the B1 chain. , 1989, The Journal of biological chemistry.

[33]  D. Lane,et al.  Heparin: Chemical and Biological Properties Clinical Applications , 1989 .

[34]  J. Chang.  Binding of heparin to human antithrombin III activates selective chemical modification at lysine 236. Lys-107, Lys-125, and Lys-136 are situated within the heparin-binding site of antithrombin III. , 1989, The Journal of biological chemistry.

[35]  A. Cardin,et al.  Molecular Modeling of Protein‐Glycosaminoglycan Interactions , 1989, Arteriosclerosis.

[36]  A. Skubitz,et al.  A novel synthetic peptide from the B1 chain of laminin with heparin- binding and cell adhesion-promoting activities , 1988, The Journal of cell biology.

[37]  R Guillemin,et al.  Receptor- and heparin-binding domains of basic fibroblast growth factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Chang,et al.  The heparin binding site of human antithrombin III. Selective chemical modification at Lys114, Lys125, and Lys287 impairs its heparin cofactor activity. , 1987, The Journal of biological chemistry.

[39]  Florante A. Quiocho,et al.  Stabilization of charges on isolated ionic groups sequestered in proteins by polarized peptide units , 1987, Nature.

[40]  J. Smith,et al.  A heparin binding site in antithrombin III. Identification, purification, and amino acid sequence. , 1987, The Journal of biological chemistry.

[41]  K. Weisgraber,et al.  Human apolipoprotein B-100 heparin-binding sites. , 1987, The Journal of biological chemistry.

[42]  C. Noyes,et al.  Identification of a lysyl residue in antithrombin which is essential for heparin binding. , 1987, The Journal of biological chemistry.

[43]  V. Dixit,et al.  Characterization of a cDNA encoding the heparin and collagen binding domains of human thrombospondin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. O’Brien,et al.  Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. , 1986, Science.

[45]  J. Sparrow,et al.  Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains. , 1986, Biochemical and biophysical research communications.

[46]  R. Houghten.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Loscalzo,et al.  The interaction of platelet factor four and glycosaminoglycans. , 1985, Archives of biochemistry and biophysics.

[48]  R. Houghten,et al.  Chemical synthesis of an octadecapeptide with the biological and immunological properties of human heat-stable Escherichia coli enterotoxin. , 1984, European journal of biochemistry.

[49]  P. K. Smith,et al.  Colorimetric method for the assay of heparin content in immobilized heparin preparations. , 1980, Analytical biochemistry.

[50]  L. McCoy,et al.  Primary structure of human platelet factor 4. , 1977, Thrombosis research.

[51]  I. Danishefsky,et al.  Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor. , 1976, Thrombosis research.

[52]  R. B. Merrifield.  Solid phase peptide synthesis. I. the synthesis of a tetrapeptide , 1963 .

[53]  A. Cardin,et al.  Heparin binding properties of the carboxyl terminal domain of [A103,106,108] antistasin 93-119. , 1992, Advances in experimental medicine and biology.

[54]  L. Kjellén,et al.  Proteoglycans: structures and interactions. , 1991, Annual review of biochemistry.

[55]  R. Linhardt,et al.  Heparin, Heparinoids and Heparin Oligosaccharides: Structure and Biological Activities , 1990 .